| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer | SVP, General Counsel
1 company
Herrmann John A III is an EVP, Chief Legal Officer at NOVAVAX INC. Recent SEC Form 4 filings include 0 buys and 77 sells.
Estimated insider holdings value: $139K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 2,896 | $212.65 | $615,847.60 | -14.8% | -3.5% | -75.8% | |
| May 28, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 2,895 | $149.14 | $431,747.85 | -35.6% | +56.0% | -62.5% | |
| Apr 30, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 2,895 | $239.83 | $694,317.13 | -18.1% | -22.3% | -81.0% | |
| Mar 26, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 2,894 | $186.80 | $540,609.15 | -14.8% | +5.7% | -59.3% | |
| Feb 26, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 2,895 | $225.48 | $652,759.28 | -12.3% | - | - | |
| Feb 1, 2021 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 15,022 | $241.50 | $3,627,788.72 | -30.7% | - | - | |
| Sep 29, 2020 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 42,779 | $109.04 | $4,664,546.09 | -12.8% | - | - | |
| Aug 18, 2020 | NVAX Novavax Inc | EVP, Chief Legal Officer | Sale+OE | 46,242 | $144.33 | $6,673,982.40 | -67.6% | - | - | |
| May 18, 2020 | NVAX Novavax Inc | SVP, General Counsel | Sale+OE | 12,961 | $49.44 | $640,791.84 | -95.9% | - | - | |
| Sep 17, 2019 | NVAX Novavax Inc | SVP, General Counsel | Sell | 3,643 | $7.07 | $25,756.74 | -100% | - | - |